Structure Therapeutics Inc. American Depositary Shares (GPCR · NASDAQ)
GPCR · MARKET VIEW
Market view · as of Jun 1, 2026
Revenue (TTM)
$0
0.0% YoY
EPS (latest q)
$-0.35
vs $-0.35 est · in line
52-wk position
28.8%
-58.9% vs 52w high · -8.7% 1mo
Price (last ~year)
Structure Therapeutics (GPCR) shares have declined 35.4% over the past three months to close at $38.55, currently trading 17.6% below the 200-day moving average. The clinical-stage biopharmaceutical company reported zero TTM revenue and a $76.2 million net loss for the quarter ending March 31, 2026. As of that date, the firm held $316.2 million in cash against $5.8 million in total debt, supporting a market capitalization of $2.80 billion.
Valuation
- Market cap
- $2.80B
- P/B
- 1.932
- EV/EBITDA
- -13.46
- Beta
- -1.39
- Analyst target
- $106.47
Quality & returns
- Operating margin
- 0.0%
- Profit margin
- 0.0%
- ROE
- -11.9%
- ROA
- -9.4%
Price movement
- Last
- $38.55
- 1-month
- -8.7%
- 3-month
- -35.4%
- RSI (14)
- 51
- vs SMA200
- -17.6%
- 52-wk position
- 28.8% -58.9% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $0 | $-89.6M | $-76.2M | $-88.4M |
| 2025-12-31 | $0 | $24.0M | $33.0M | $33.6M |
| 2025-09-30 | $0 | $-73.8M | $-65.7M | $-65.3M |
| 2025-06-30 | $0 | $-70.5M | $-61.7M | $-70.2M |
Recent news
- Neutral GPCR Financials: Revenue Breakdown, Margins & Competitor Comparison · 2026-05-27
- Neutral Hear Structure Therapeutics at Jefferies and Goldman Sachs healthcare talks · 2026-05-26
- Neutral Number of shareholders of Structure Therapeutics Inc. – NASDAQ:GPCR · 2026-05-25
- Somewhat-Bearish Why (GPCR) Price Action Is Critical for Tactical Trading · 2026-05-24
- Somewhat-Bullish GPCR News | STRUCTURE THERAPEUTICS INC (NASDAQ:GPCR) · 2026-05-22
- Neutral GPCR Stock Chart | STRUCTURE THERAPEUTICS INC (NASDAQ:GPCR) · 2026-05-22
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)